103 related articles for article (PubMed ID: 309586)
1. [Assessment of the effect of immunosuppression on leukocyte migration inhibition in various autoimmune diseases in children].
Lukas A; Cesarz E; Sliwa F; Lukas W; Sychłowy A
Pediatr Pol; 1978 Nov; 53(11):1271-5. PubMed ID: 309586
[No Abstract] [Full Text] [Related]
2. [Basis of immunosuppressive effect of D-penecillamine].
Schumacher K
Internist (Berl); 1975 Oct; 16(10):460-5. PubMed ID: 1107252
[No Abstract] [Full Text] [Related]
3. [Immunosuppression: bioligical bases and usage].
Wilmanns W
Internist (Berl); 1975 Oct; 16(10):451-9. PubMed ID: 1107251
[No Abstract] [Full Text] [Related]
4. [Non-specific immunosuppressive methods and their problems].
Kanoh T; Uchino H
Nihon Rinsho; 1981 Apr; 39(4):1827-32. PubMed ID: 7031295
[No Abstract] [Full Text] [Related]
5. [Immunologic and pharmacological principles for the use of immunosuppressive drugs in autoimmune diseases].
Floersheim GL
Schweiz Med Wochenschr; 1970 Dec; 100(52):2241-7. PubMed ID: 4946978
[No Abstract] [Full Text] [Related]
6. [Immunosuppression by means of antilymphocyte serums in humans].
Revillard JP
Nouv Rev Fr Hematol; 1972; 12(2):129-37. PubMed ID: 4264610
[No Abstract] [Full Text] [Related]
7. Rationale for T cell inhibition by cyclosporin A in major autoimmune diseases.
Ferraccioli GF; Tomietto P; De Santis M
Ann N Y Acad Sci; 2005 Jun; 1051():658-65. PubMed ID: 16127006
[TBL] [Abstract][Full Text] [Related]
8. Report on immunosuppressive therapy.
Arch Immunol Ther Exp (Warsz); 1975; 23(2):161-76. PubMed ID: 1147741
[No Abstract] [Full Text] [Related]
9. Immunosuppressive therapy in internal medicine.
Moeschlin S
Verh K Acad Geneeskd Belg; 1973; 35(1):72-94. PubMed ID: 4730763
[No Abstract] [Full Text] [Related]
10. [Theoretical basis of immunosuppression in autoimmune diseases].
Haustein UF
Dermatol Monatsschr; 1972 Aug; 158(8):547-71. PubMed ID: 4404036
[No Abstract] [Full Text] [Related]
11. Multiple sclerosis is an inflammatory T-cell-mediated autoimmune disease.
Weiner HL
Arch Neurol; 2004 Oct; 61(10):1613-5. PubMed ID: 15477521
[No Abstract] [Full Text] [Related]
12. [Immunosuppression].
Koltay M; Virág I
Orv Hetil; 1968 Feb; 109(5):231-4. PubMed ID: 5686748
[No Abstract] [Full Text] [Related]
13. [Autoagression and immunosuppression in dermatology. 3. Immunosuppression in autoagressive dermatoses].
Novotný F
Cesk Dermatol; 1973 Jan; 48(1):43-9. PubMed ID: 4687385
[No Abstract] [Full Text] [Related]
14. Therapeutic strategies in autoimmune diseases: the search for tolerance induction.
Bach JF
Transplant Proc; 1994 Dec; 26(6):3188-90. PubMed ID: 7998110
[No Abstract] [Full Text] [Related]
15. [What is certain in the treatment with immunosuppressive agents?].
Malchow H
Internist (Berl); 1971 Dec; 12(12):504-12. PubMed ID: 4944681
[No Abstract] [Full Text] [Related]
16. Therapeutic strategies in autoimmune disease: cyclosporin A as a model agent.
Lemley DE; Katz P
In Vivo; 1988; 2(1):115-8. PubMed ID: 2979810
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacology of chemical immunosuppression].
Potel J; Brock N
Verh Dtsch Ges Rheumatol; 1972; 2():Suppl 2:339-57. PubMed ID: 5051958
[No Abstract] [Full Text] [Related]
18. Design of PAP-1, a selective small molecule Kv1.3 blocker, for the suppression of effector memory T cells in autoimmune diseases.
Schmitz A; Sankaranarayanan A; Azam P; Schmidt-Lassen K; Homerick D; Hänsel W; Wulff H
Mol Pharmacol; 2005 Nov; 68(5):1254-70. PubMed ID: 16099841
[TBL] [Abstract][Full Text] [Related]
19. [Preliminary studies on immunosuppressive therapy of connective tissue disorders].
Gillardi U; Liso V; Troccoli G
Haematologica; 1970 Dec; 55(12):759-65. PubMed ID: 5003115
[No Abstract] [Full Text] [Related]
20. [Immunosuppressive cytostatic preparations in the therapy of certain diseases].
Petrov NS; Dygin VP; Viazitskiĭ PO; Tokarev NF
Voen Med Zh; 1975 Sep; (9):43-7. PubMed ID: 1181721
[No Abstract] [Full Text] [Related]
[Next] [New Search]
